Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-22

Clinical Trial Update: Treating Pyelonephritis an Urosepsis With Pivmecillinam [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating pivmecillinam for pyelonephritis and urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pivmecillinam (pivmecillinam)

Snippet

Sponsor: Sykehuset i Vestfold HF | Conditions: Pyelonephritis, Urinary Tract Infections | Phase 4 | Status: COMPLETED